Alvotech Quality Score
ALVO
Weak across most dimensions. This doesn't mean avoid, but the burden of proof is on the bull case.
Broad-market heuristics · Not a buy/sell signal
Valuation and growth
Valuation
Growth
Negative earnings, no valuation support
Negative FCF, no valuation support
Above 10% CAGR, strong compounder
FCF negative, burning cash after capex
Business Quality & Capital Allocation
Heavy dilution above 5%
Expanded 3+pp, strong improvement
Positive debt with no FCF to service it
Below 8%, may not cover cost of capital
Alvotech (ALVO) quality: score, margins and returns
Alvotech (ALVO) scores 30/100 on Intrinsiqq's quality score (a lower-quality business), a weighted blend of 6 metrics each scored 0 to 100, on 9.7% operating margins and 3.0% ROIC. Every metric is computed from company filings; this is analysis, not investment advice.
Frequently asked
Is Alvotech (ALVO) a high-quality business?+
Alvotech scores 30 out of 100 on Intrinsiqq's quality score, a weighted blend of 6 metrics each scored 0 to 100, which rates it a lower-quality business on these measures. Recent figures include a 9.7% operating margin and a 3.0% return on invested capital. Quality and price are separate questions: even a great business can be a poor investment if you overpay, so read this score alongside the valuation. The metric-by-metric breakdown is on this scorecard.
What does Alvotech's quality score measure?+
Intrinsiqq's quality score weighs revenue and free-cash-flow growth, operating margins, return on invested capital, change in share count, and balance-sheet strength, each computed from ALVO's company filings rather than opinion or sentiment. A higher score means a more durable, capital-efficient business; it is not a buy or sell signal. Open each metric on this page to see exactly where Alvotech scores well and where it falls behind.
What is Alvotech's return on invested capital (ROIC)?+
Alvotech earns about 3.0% on its invested capital, which is weak. ROIC measures how much profit a company generates per dollar put to work; sustained ROIC above its cost of capital is one of the clearest signs of a real competitive moat. Compare it to ALVO's margins and growth on this scorecard to judge durability.
How profitable is Alvotech?+
Alvotech runs an operating margin of about 9.7% and a net margin of about -36.5%. Revenue has grown at roughly 99.8% a year recently. High, stable margins usually point to pricing power and operating discipline. Margins are most telling next to growth and returns on capital, all of which feed this quality score. This is analysis from company filings, not investment advice.
Peers
Drug Manufacturers - Specialty & Generic · Pick stocks to compare with ALVO
Held by ETFs
ALVO is in 9 US ETFs. The largest of them, with ALVO's weight in each:
Fidelity Nasdaq Composite Index ETFONEQ0.01%of the fund
iShares Biotechnology ETFIBB0.06%of the fund
SPDR S&P Emerging Markets Small Cap ETFEWX0.08%of the fund
Vanguard Emerging Markets Ex-China ETFVEXC0.01%of the fund
iShares Genomics Immunology and Healthcare ETFIDNA0.47%of the fund
ProShares Ultra Nasdaq BiotechnologyBIB0.06%of the fund
Spot a number that looks wrong?
Download this analysis as a PDF (Pro)
Data sourced from company filings and third-party price providers. Scores, valuations, and metrics are algorithmic estimates. This is not investment advice. See our Terms and Methodology.
Keep analysing ALVO
A free account gives you 10 stocks a day, a watchlist and price alerts.
Already have an account?
Or come back tomorrow. Stocks on your watchlist are always free to view.